The Comparison of RCD Versus BCD in Newly Diagnosed Waldenström Macroglobulinemia
Status:
Unknown status
Trial end date:
2020-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the efficacy of cyclophosphamide plus dexamethasone
combined with rituximab or bortezomib regimens in newly diagnosed Waldenström
macroglobulinemia patients.